<?xml version="1.0" encoding="UTF-8"?>
<p id="p0170">The process mapping workshops culminated in production of a website, with standalone pages for maps that distinguished the following major subdivisions: (1) Target Product Profile (TPP); (2) Pre-clinical Discovery; (3) Pre-clinical Development; (4) Clinical Development; and (5) Regulatory Affairs and Ethical Approvals (
 <xref rid="f0005" ref-type="fig">Fig. 1</xref> ). Due to the mandate and remit of the tool to be used by the UKVN for the development of vaccines for outbreaks, WG3 agreed that the tool did not need to address steps for market access and authorisation, as outbreak vaccines would not normally undergo this process â€“ instead being deployed in small populations according to need once necessary evidence on safety and immunogenicity had been achieved.
</p>
